Neurology and Neurosurgery

Episodes 17-32 of 351

Transitioning to Adult Care in DMD: Strategies for Long-Term Support
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiers
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
- Rosaline Quinlivan
The Complexities of DMD: Optimizing Multidisciplinary Care
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiers
The Complexities of DMD: Optimizing Multidisciplinary Care
- Rosaline Quinlivan
Reducing the Burden of gMG with a Novel B-Cell Therapy
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiers
Reducing the Burden of gMG with a Novel B-Cell Therapy
- Richard Nowak, MD, MS
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiers
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
- Richard Nowak, MD, MS
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiers
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiers
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
- Andrew J. Solomon, MD
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Global Neurology Academy
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
NeuroFrontiers
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
- Charles Turck, PharmD, BCPS, BCCCP
- Jason Ackrivo, MD, MSCE
- Bethany Lussier, MD
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Global Neurology Academy
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
- Mark Gudesblatt, MD
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
NeuroFrontiers
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
- Prajwal Ciryam, MD, PhD
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiers
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
- Kelly Sloane, MD
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Global Neurology Academy
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
- Charles Turck, PharmD, BCPS, BCCCP
- Yinan Zhang, MD
- Sarah A. Morrow, MD, MS, FRCPC, FAAN
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
Global Neurology Academy
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
- Marisa McGinley, DO
Mapping Brain Atrophy in Schizophrenia
Mapping Brain Atrophy in Schizophrenia
Neurology and Neurosurgery
Mapping Brain Atrophy in Schizophrenia
- Ahmed Makhlouf, MD
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Global Neurology Academy
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
- Charles Turck, PharmD, BCPS, BCCCP
- Kimberly DiMauro, DO
- Carol Swetlik, MD

2/7

Neurology and Neurosurgery

Episodes 17-32 of 351

NEED HELP?

Contact us

NEED HELP?

Contact us

Episodes 17-32 of 351

Title

Share on ReachMD